Summary
65 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 138% a year over the last 3 years.
- It has raised its dividend 25 years in a row and pays out only 38% of profit.
- Out of every 100 USD of revenue, 12 USD is left as net profit.
- It bought back its own shares for $100.1M in the last fiscal year, 3.9% of its market value.
What to watch
- Revenue fell by 6.0% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- Repaying its net debt would take 3.6 years of operating profit.
- It earns only 5.9 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensivePrice against the Bulios Fair Price
P/E against the industry (Publishing)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.0 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 2.9% a year over 5 years. Over the last 3 years it fell by 6.0% a year. Earnings per share grew by 138% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 28 USD
- Sales and administration 54 USD
- Taxes and other 4.0 USD
- Net profit 12 USD
Net profit, industry median (Publishing) 27 USD
Out of every 100 USD of revenue, 12 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 6.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, safe- Yield
- 2.89%
- Paid out of profit
- 38%
- Raised in a row
- 25 years
You receive $1.42 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 1
- Hold 2
- Sell 0
No analyst has published a price target.
33% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Research Segment 64%
- Learning Segment 35%
- Held For Sale Or Sold Segment 1.0%
By region
- UNITED STATES 47%
- Other Countries 34%
- CHINA 9.1%
- JAPAN 5.3%
- AUSTRALIA 4.8%
Research Segment brings in 64% of revenue.
Segments in detail